c2544856
Senate
s0300-98
s0370
2002
AA
104940
Senator Saunders moved the following amendment to amendment
(104940):
On page 97, between lines 23 and 24,
On page 107, line 21,




                                                  SENATE AMENDMENT

    Bill No. CS for CS for SB 370

    Amendment No. ___   Barcode 544856

                            CHAMBER ACTION
              Senate                               House
                                   .
                                   .
  1                                .
                                   .
  2                                .
                                   .
  3                                .
                                   .
  4  ______________________________________________________________

  5

  6

  7

  8

  9

10  ______________________________________________________________

11  Senator Saunders moved the following amendment to amendment

12  (104940):

13

14         Senate Amendment (with title amendment) 

15         On page 97, between lines 23 and 24,

16

17  insert:

18         Section 80.  Subsection (7) of section 409.91195,

19  Florida Statutes, is amended to read:

20         409.91195  Medicaid Pharmaceutical and Therapeutics

21  Committee.--There is created a Medicaid Pharmaceutical and

22  Therapeutics Committee within the Agency for Health Care

23  Administration for the purpose of developing a preferred drug

24  formulary pursuant to 42 U.S.C. s. 1396r-8.

25         (7)  The committee shall ensure that interested

26  parties, including pharmaceutical manufacturers agreeing to

27  provide a supplemental rebate as outlined in this chapter,

28  have an opportunity to present public testimony to the

29  committee with information or evidence supporting inclusion of

30  a product on the preferred drug list. The committee shall take

31  public testimony prior to making any recommendations made by

                                  1
    2:14 PM   03/20/02                              s0370c2c-25r01




                                                  SENATE AMENDMENT

    Bill No. CS for CS for SB 370

    Amendment No. ___   Barcode 544856





  1  the committee for inclusion or exclusion from the preferred

  2  drug list. Upon timely notice, the agency shall ensure that

  3  any drug that has been approved or had any of its particular

  4  uses approved by the United States Food and Drug

  5  Administration under a priority review classification will be

  6  reviewed by the Medicaid Pharmaceutical and Therapeutics

  7  Committee at the next regularly scheduled meeting. To the

  8  extent possible, upon notice by a manufacturer the agency

  9  shall also schedule a product review for any new product at

10  the next regularly scheduled Medicaid Pharmaceutical and

11  Therapeutics Committee.

12

13  (Redesignate subsequent sections.)

14

15

16  ================ T I T L E   A M E N D M E N T ===============

17  And the title is amended as follows:

18         On page 107, line 21, after the semicolon,

19

20  insert:

21         amending s. 409.91195, F.S., relating to the

22         Medicaid Pharmaceutical and Therapeutics

23         Committee; requiring that the committee take

24         public testimony;

25

26

27

28

29

30

31

                                  2
    2:14 PM   03/20/02                              s0370c2c-25r01